Foresite Capital Management II, LLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.

Quarter-by-quarter ownership
Foresite Capital Management II, LLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$7,897,000
+37.1%
45,8840.0%2.81%
+81.1%
Q2 2021$5,758,000
-7.5%
45,8840.0%1.55%
+8.3%
Q1 2021$6,222,000
+6.0%
45,8840.0%1.43%
-7.7%
Q4 2020$5,870,000
+13.7%
45,8840.0%1.55%
+38.0%
Q3 2020$5,163,000
+55.8%
45,884
+31.9%
1.12%
+72.5%
Q2 2020$3,314,000
+6.0%
34,7840.0%0.65%
-10.8%
Q1 2020$3,126,000
-68.7%
34,784
-81.6%
0.73%
-55.7%
Q4 2019$10,000,000
+34.2%
188,6020.0%1.65%
+4.6%
Q3 2019$7,452,000
-3.8%
188,6020.0%1.58%
-63.8%
Q2 2019$7,748,000
-11.8%
188,6020.0%4.36%
+9.9%
Q1 2019$8,783,000
-3.8%
188,602
-10.0%
3.96%
-18.0%
Q4 2018$9,128,000
-27.6%
209,602
-4.8%
4.84%
+3.7%
Q3 2018$12,606,000
+6.1%
220,268
-10.0%
4.66%
+11.5%
Q2 2018$11,876,000
+24.1%
244,7560.0%4.18%
+31.4%
Q1 2018$9,570,000
-7.9%
244,7560.0%3.18%
-12.3%
Q4 2017$10,387,000
+13.7%
244,7560.0%3.63%
-2.0%
Q3 2017$9,134,000
+1633.2%
244,756
+1129.3%
3.70%
+1538.1%
Q1 2017$527,000
+3.7%
19,9100.0%0.23%
-11.4%
Q4 2016$508,000
-69.4%
19,910
-59.2%
0.26%
-77.5%
Q2 2016$1,660,000
-63.9%
48,839
-71.9%
1.14%
-49.5%
Q1 2016$4,594,000
-31.5%
174,089
+26.6%
2.25%
+0.0%
Q4 2015$6,702,000
+35.4%
137,458
-30.8%
2.25%
+49.6%
Q3 2015$4,948,000
+402.8%
198,717
+539.0%
1.50%
+335.4%
Q2 2015$984,00031,1000.34%
Other shareholders
ACCELERON PHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
Polaris Venture Management Co IV LLC 1,480,060$53,563,00085.86%
NEXTHERA CAPITAL LP 217,817$7,883,0004.84%
Novo Holdings A/S 903,833$32,710,0002.90%
SECTORAL ASSET MANAGEMENT INC 481,765$17,435,0001.71%
Perceptive Advisors 589,890$21,348,0001.38%
RA Capital Management 318,565$11,529,0001.19%
OAK RIDGE INVESTMENTS LLC 1,226,468$44,386,0001.15%
Granahan Investment Management 817,149$29,573,0000.97%
Eventide Asset Management 428,900$15,522,0000.95%
QVT Financial LP 636,764$23,044,0000.87%
View complete list of ACCELERON PHARMA INC shareholders